| Thromboembolism |
1 |
0.67 |
| Asthma |
0 |
0.61 |
| Smoking |
0 |
0.55 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.48 |
| Biologic Therapy |
0 |
0.39 |
| Rheumatoid Arthritis |
0 |
1 |
| Tobacco Cessation |
0 |
0.39 |
| Cardiovascular disease |
0 |
0.55 |
| Venous Thromboembolism (VTE) |
0 |
0.55 |
| Otolaryngology |
0 |
0.31 |
| Anti-Tumor Necrosis Factor (Anti-TNF) |
0 |
0.55 |
| Cardiovascular Risk Management |
0 |
0.26 |
| Interstitial Lung Disease |
0 |
0.75 |
| Airway |
0 |
0.18 |
| Antineoplastic Drug |
0 |
0.18 |
| Arthritis |
0 |
0.18 |
| Disease-Modifying Antirheumatic Drugs |
0 |
0.18 |
| Embolism |
0 |
0.18 |
| Lung |
0 |
0.18 |
| Monoclonal Antibody |
0 |
0.55 |
| Pulmonary Embolism |
0 |
0.18 |
| Tumor |
0 |
0.18 |
| Myocardial Infarction (MI) |
0 |
0.13 |